BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25284589)

  • 1. Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction.
    Cetinbas N; Daugaard M; Mullen AR; Hajee S; Rotblat B; Lopez A; Li A; DeBerardinis RJ; Sorensen PH
    Oncogene; 2015 Jul; 34(30):4005-10. PubMed ID: 25284589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes.
    Daugaard M; Nitsch R; Razaghi B; McDonald L; Jarrar A; Torrino S; Castillo-Lluva S; Rotblat B; Li L; Malliri A; Lemichez E; Mettouchi A; Berman JN; Penninger JM; Sorensen PH
    Nat Commun; 2013; 4():2180. PubMed ID: 23864022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HACE1, an E3 Ubiquitin Protein Ligase, Mitigates Kaposi's Sarcoma-Associated Herpesvirus Infection-Induced Oxidative Stress by Promoting Nrf2 Activity.
    Kumar B; Roy A; Asha K; Sharma-Walia N; Ansari MA; Chandran B
    J Virol; 2019 May; 93(9):. PubMed ID: 30787155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HACE1 is a potential tumor suppressor in osteosarcoma.
    El-Naggar AM; Clarkson PW; Negri GL; Turgu B; Zhang F; Anglesio MS; Sorensen PH
    Cell Death Dis; 2019 Jan; 10(1):21. PubMed ID: 30622235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of glutamine metabolism by the tumor suppressor Rb.
    Reynolds MR; Lane AN; Robertson B; Kemp S; Liu Y; Hill BG; Dean DC; Clem BF
    Oncogene; 2014 Jan; 33(5):556-66. PubMed ID: 23353822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-dependent anaplerosis in cancer cells is required for cellular redox balance in the absence of glutamine.
    Cetinbas NM; Sudderth J; Harris RC; Cebeci A; Negri GL; Yılmaz ÖH; DeBerardinis RJ; Sorensen PH
    Sci Rep; 2016 Sep; 6():32606. PubMed ID: 27605385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hace1 Influences zebrafish cardiac development via ROS-dependent mechanisms.
    Razaghi B; Steele SL; Prykhozhij SV; Stoyek MR; Hill JA; Cooper MD; McDonald L; Lin W; Daugaard M; Crapoulet N; Chacko S; Lewis SM; Scott IC; Sorensen PHB; Berman JN
    Dev Dyn; 2018 Feb; 247(2):289-303. PubMed ID: 29024245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases.
    Kogler M; Tortola L; Negri GL; Leopoldi A; El-Naggar AM; Mereiter S; Gomez-Diaz C; Nitsch R; Tortora D; Kavirayani AM; Gapp BV; Rao S; Uribesalgo I; Hoffmann D; Cikes D; Novatchkova M; Williams DA; Trent JM; Ikeda F; Daugaard M; Hagelkruys A; Sorensen PH; Penninger JM
    Cancer Res; 2020 Jul; 80(14):3009-3022. PubMed ID: 32366477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
    Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
    Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes.
    Turgu B; El-Naggar A; Kogler M; Tortola L; Zhang HF; Hassan M; Lizardo MM; Kung SH; Lam W; Penninger JM; Sorensen PH
    EMBO Rep; 2023 Dec; 24(12):e56815. PubMed ID: 37846480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress.
    Zhang L; Chen X; Sharma P; Moon M; Sheftel AD; Dawood F; Nghiem MP; Wu J; Li RK; Gramolini AO; Sorensen PH; Penninger JM; Brumell JH; Liu PP
    Nat Commun; 2014 Mar; 5():3430. PubMed ID: 24614889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response.
    Rotblat B; Southwell AL; Ehrnhoefer DE; Skotte NH; Metzler M; Franciosi S; Leprivier G; Somasekharan SP; Barokas A; Deng Y; Tang T; Mathers J; Cetinbas N; Daugaard M; Kwok B; Li L; Carnie CJ; Fink D; Nitsch R; Galpin JD; Ahern CA; Melino G; Penninger JM; Hayden MR; Sorensen PH
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3032-7. PubMed ID: 24516159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation.
    Castillo-Lluva S; Tan CT; Daugaard M; Sorensen PH; Malliri A
    Oncogene; 2013 Mar; 32(13):1735-42. PubMed ID: 22614015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1.
    Torrino S; Visvikis O; Doye A; Boyer L; Stefani C; Munro P; Bertoglio J; Gacon G; Mettouchi A; Lemichez E
    Dev Cell; 2011 Nov; 21(5):959-65. PubMed ID: 22036506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HACE1 negatively regulates neuroinflammation through ubiquitylating and degrading Rac1 in Parkinson's disease models.
    Zang CX; Wang L; Yang HY; Shang JM; Liu H; Zhang ZH; Ju C; Yuan FY; Li FY; Bao XQ; Zhang D
    Acta Pharmacol Sin; 2022 Feb; 43(2):285-294. PubMed ID: 34593974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate.
    Tortola L; Nitsch R; Bertrand MJM; Kogler M; Redouane Y; Kozieradzki I; Uribesalgo I; Fennell LM; Daugaard M; Klug H; Wirnsberger G; Wimmer R; Perlot T; Sarao R; Rao S; Hanada T; Takahashi N; Kernbauer E; Demiröz D; Lang M; Superti-Furga G; Decker T; Pichler A; Ikeda F; Kroemer G; Vandenabeele P; Sorensen PH; Penninger JM
    Cell Rep; 2016 May; 15(7):1481-1492. PubMed ID: 27160902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress is not required for the induction of apoptosis upon glutamine starvation of Sp2/0-Ag14 hybridoma cells.
    Guérin PJ; Furtak T; Eng K; Gauthier ER
    Eur J Cell Biol; 2006 May; 85(5):355-65. PubMed ID: 16412532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.
    Zhang L; Anglesio MS; O'Sullivan M; Zhang F; Yang G; Sarao R; Mai PN; Cronin S; Hara H; Melnyk N; Li L; Wada T; Liu PP; Farrar J; Arceci RJ; Sorensen PH; Penninger JM
    Nat Med; 2007 Sep; 13(9):1060-9. PubMed ID: 17694067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation.
    Andrio E; Lotte R; Hamaoui D; Cherfils J; Doye A; Daugaard M; Sorensen PH; Bost F; Ruimy R; Mettouchi A; Lemichez E
    Sci Rep; 2017 Mar; 7():44779. PubMed ID: 28317937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo.
    Ehrnhoefer DE; Southwell AL; Sivasubramanian M; Qiu X; Villanueva EB; Xie Y; Waltl S; Anderson L; Fazeli A; Casal L; Felczak B; Tsang M; Hayden MR
    Hum Mol Genet; 2018 Jan; 27(2):239-253. PubMed ID: 29121340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.